AXIOM INTERESTING THAT ONCE THE DISTRIBUTOR GOT CALYPTE APPROVED IN INDIA THAT CALYPTE'S RESPONSE WAS TO DUMP THE DISTRIBUTOR FOR A BIGGER AND BETTER DISTRIBUTOR. REALLY CONFIDENCE INSPIRING TO DEAL WITH CALYPTE ISN'T IT. ---> Strickly business, kinda shady though I admit.
IN ADDITION IT APPEARS THERE IS TROUBLE IN RUSSIA. RAPID ORAL APPROVED IN RUSSIA BUT RUSSIA WON'T LET THEM SELL IT? WHAT DOES THAT MEAN? ---> Sounded like Russia left the Calypte test off of a specified list, it has now been added and should be cleared for sale.
ALSO
ROGER SAID THAT THE USAID APPROVAL WAS THE FIRST TIME THEY HAD ACCESS TO FUNDS FROM USAID. DID HE FORGET THAT THE RAPID BLOOD TEST HAS BEEN ON THE USAID approved LIST FOR OVER A YEAR. APPARENTLY SO. ---> Agreed, I think they've given up on competeing with their blood test.
Good News is that this interview only cost Calypte $ 280. Much better than the amount they pay CEOcast for their "coverage".
They are making some make or break strides though and trying to position themselves all over the world. In my opinion, its only a matter of time before the Aware OMT starts to bring in some revenue. They are in a much better position now then they were two years ago.
News 
Market Data 
Discover 
AI
